Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.

Adusumilli PS, Cherkassky L, Villena-Vargas J, Colovos C, Servais E, Plotkin J, Jones DR, Sadelain M.

Sci Transl Med. 2014 Nov 5;6(261):261ra151. doi: 10.1126/scitranslmed.3010162.

2.

Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.

Nitadori JI, Colovos C, Kadota K, Sima CS, Sarkaria IS, Rizk NP, Rusch VW, Travis WD, Adusumilli PS.

Chest. 2013 Nov;144(5):1622-1631. doi: 10.1378/chest.13-0394.

3.

Safety and stability of retrovirally transduced chimeric antigen receptor T cells.

Colovos C, Villena-Vargas J, Adusumilli PS.

Immunotherapy. 2012 Sep;4(9):899-902. doi: 10.2217/imt.12.91.

PMID:
23046233
4.

FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.

Kadota K, Colovos C, Suzuki K, Rizk NP, Dunphy MP, Zabor EC, Sima CS, Yoshizawa A, Travis WD, Rusch VW, Adusumilli PS.

Ann Surg Oncol. 2012 Oct;19(11):3598-605. doi: 10.1245/s10434-012-2414-3. Epub 2012 May 30.

5.

Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients.

Servais EL, Colovos C, Rodriguez L, Bograd AJ, Nitadori J, Sima C, Rusch VW, Sadelain M, Adusumilli PS.

Clin Cancer Res. 2012 May 1;18(9):2478-89. doi: 10.1158/1078-0432.CCR-11-2614. Epub 2012 Feb 27.

6.

An in vivo platform for tumor biomarker assessment.

Servais EL, Suzuki K, Colovos C, Rodriguez L, Sima C, Fleisher M, Rusch VW, Sadelain M, Adusumilli PS.

PLoS One. 2011;6(10):e26722. doi: 10.1371/journal.pone.0026722. Epub 2011 Oct 26.

7.

A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.

Kadota K, Suzuki K, Colovos C, Sima CS, Rusch VW, Travis WD, Adusumilli PS.

Mod Pathol. 2012 Feb;25(2):260-71. doi: 10.1038/modpathol.2011.146. Epub 2011 Oct 7.

8.

Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.

Bograd AJ, Suzuki K, Vertes E, Colovos C, Morales EA, Sadelain M, Adusumilli PS.

Cancer Immunol Immunother. 2011 Nov;60(11):1509-27. doi: 10.1007/s00262-011-1103-6. Epub 2011 Sep 13. Review.

9.

Pre-clinical mouse models of primary and metastatic pleural cancers of the lung and breast and the use of bioluminescent imaging to monitor pleural tumor burden.

Servais EL, Colovos C, Kachala SS, Adusumilli PS.

Curr Protoc Pharmacol. 2011 Sep;Chapter 14:Unit14.21. doi: 10.1002/0471141755.ph1421s54.

10.

Animal models and molecular imaging tools to investigate lymph node metastases.

Servais EL, Colovos C, Bograd AJ, White J, Sadelain M, Adusumilli PS.

J Mol Med (Berl). 2011 Aug;89(8):753-69. doi: 10.1007/s00109-011-0764-0. Epub 2011 May 10. Review.

11.

Slumdog's silent killer.

Bharel S, Colovos C, Ngai DA, Adusumilli PS.

Natl Med J India. 2010 Sep-Oct;23(5):305-6. No abstract available.

PMID:
21250590
12.

The impact of scoliosis among patients with giant paraesophageal hernia.

Schuchert MJ, Adusumilli PS, Cook CC, Colovos C, Kilic A, Nason KS, Landreneau JP, Zikos T, Jack R, Luketich JD, Landreneau RJ.

J Gastrointest Surg. 2011 Jan;15(1):23-8. doi: 10.1007/s11605-010-1307-7. Epub 2010 Sep 8.

PMID:
20824386
13.

Surgeons and simulators.

Colovos C, Suzuki K, Leitman IM, Adusumilli PS.

Natl Med J India. 2009 Nov-Dec;22(6):323-4. No abstract available.

PMID:
20384025
14.

Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center.

Gusani NJ, Cho SW, Colovos C, Seo S, Franko J, Richard SD, Edwards RP, Brown CK, Holtzman MP, Zeh HJ, Bartlett DL.

Ann Surg Oncol. 2008 Mar;15(3):754-63. Epub 2007 Dec 12.

PMID:
18080166
15.

Pilot study of fixed-infusion rate gemcitabine with Cisplatin and dexamethasone in patients with relapsed or refractory lymphoma.

Emmanouilides C, Colovos C, Pinter-Brown L, Hernandez L, Schiller G, Territo M, Rosen P.

Clin Lymphoma. 2004 Jun;5(1):45-9.

PMID:
15245607
16.

The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology.

Terwilliger TC, Park MS, Waldo GS, Berendzen J, Hung LW, Kim CY, Smith CV, Sacchettini JC, Bellinzoni M, Bossi R, De Rossi E, Mattevi A, Milano A, Riccardi G, Rizzi M, Roberts MM, Coker AR, Fossati G, Mascagni P, Coates AR, Wood SP, Goulding CW, Apostol MI, Anderson DH, Gill HS, Eisenberg DS, Taneja B, Mande S, Pohl E, Lamzin V, Tucker P, Wilmanns M, Colovos C, Meyer-Klaucke W, Munro AW, McLean KJ, Marshall KR, Leys D, Yang JK, Yoon HJ, Lee BI, Lee MG, Kwak JE, Han BW, Lee JY, Baek SH, Suh SW, Komen MM, Arcus VL, Baker EN, Lott JS, Jacobs W Jr, Alber T, Rupp B.

Tuberculosis (Edinb). 2003;83(4):223-49. Review.

PMID:
12906835
17.

Nanohedra: using symmetry to design self assembling protein cages, layers, crystals, and filaments.

Padilla JE, Colovos C, Yeates TO.

Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2217-21. Epub 2001 Feb 20.

18.

Evaluation of phase accuracy via topological and geometrical analysis of electron-density maps.

Colovos C, Toth EA, Yeates TO.

Acta Crystallogr D Biol Crystallogr. 2000 Nov;56(Pt 11):1421-9.

PMID:
11053840
19.
20.

Supplemental Content

Loading ...
Support Center